deltatrials
Completed OBSERVATIONAL NCT02348697

Non-Interventional Study to Evaluate Safety and Efficacy of NOVOCART 3D in Patients With Cartilage Defects (NISANIK)

Sponsor: Aesculap AG

Interventions NOVOCART 3D
Updated 9 times since 2017 Last updated: Dec 2, 2019 Started: Jun 30, 2015 Primary completion: Oct 30, 2019 Completion: Oct 30, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cartilage Diseases and is currently completed. Aesculap AG leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshotActive Not Recruiting~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshotActive Not Recruiting~Feb 2019 – ~Jan 2020 · 11 months · monthly snapshotActive Not Recruiting~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 11 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2021 — Jul 2024 [monthly]

    Completed

  5. Jan 2020 — Jan 2021 [monthly]

    Completed

    Status: Active Not RecruitingCompleted

Show 4 earlier versions
  1. Feb 2019 — Jan 2020 [monthly]

    Active Not Recruiting

  2. Jun 2018 — Feb 2019 [monthly]

    Active Not Recruiting

  3. Apr 2018 — Jun 2018 [monthly]

    Active Not Recruiting

    Phase: NANone

  4. Jan 2017 — Apr 2018 [monthly]

    Active Not Recruiting NA

    First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Aesculap AG
  • Tetec AG
Data source: Tetec AG

For direct contact, visit the study record on ClinicalTrials.gov .